Author:
Brown Ross,Ho P. Joy,Gibson John,Joshua Douglas
Reference172 articles.
1. Ruffini PA, Neelapu SS, Kwak L et al (2002) Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Haematologica 87:989–1001
2. Yi Q (2009) Novel immunotherapies. Cancer J 15:502–510
3. Higano CS, Schellhammer PF, Small EJ et al (2009) Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with Sipuleucel-t in advanced prostate cancer. Cancer 115:3670–3679
4. Kay N, Leong T, Kyle RA (1999) Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487). Leuk Lymphoma 33:127–133
5. Mills KHG, Cawley JC (1983) Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. Br J Haematol 53:271–275
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献